Eden Biosolutions PLC (EDEN.L) LSE

Currency In GBp

AD

Valuation

Market Cap15.14M
Enterprise Value14.29M
P/E Ratio-6.71
PEG Ratio0.17
Price/Sales Ratio5
Price/Book Ratio1.05
Enterprise/Revenue4.78
Enterprise/EBITDA-11.93

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.5
Operating Margin-0.59
AD

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.16

Income Statement

Revenue3.88M
Revenue/Share0.01
Gross Profit1.14M
EBITDA-1.56M
Net Income-1.96M
Diluted EPS-0

Balance Sheet

Total Cash1.85M
Total Cash/Share0
Total Debt571,862
Total Debt/Equity0.05
Current Ratio1.95
Book Value Per Share0.02

Price History

52-Week Change-1.43
52-Week High5
52-Week Low1.9
Moving Average 50 Days2.26
Moving Average 200 Days3.05

Statistics

Average Volume605,658
Shares Outstanding803.36M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD